A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...

Early clinical trials established the safety and feasibility of closed-loop insulin delivery, but the 2019 iDCL trial1 marked the first large, outpatient, randomised, controlled trial to show a ...

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the commercial launch in Europe of the ...

In individuals with type 2 diabetes with no previous insulin treatment, once-weekly injections of insulin icodec resulted in glucose-lowering efficacy and a safety profile similar to individuals who ...

Most types of insulin therapy, an important part of diabetes treatment for many people, are given as daily injections to help manage blood sugar levels. Now, the maker of a once-weekly insulin ...

The designation supports priority engagement with the FDA as Portal Diabetes advances clinical trials and regulatory submissions.

Stem-cell–based therapies aim to change that paradigm by repairing or replacing damaged biological systems. If replicated successfully in larger patient populations, the approach could reduce ...

Scientists succeed in creating an artificial pancreas that regulates glucose, opening the door to treating diabetes without injections.